AGA Freston Single Topic Conference 2021

American Gastroenterological Association Freston Single Topic Conference 2021

Format:16 videos, size: 7.59 GB

Course Audience: gastroenterologist

ACHALASIA (Video MP4 Format)

Breakout Emerging Therapeutics for Children. Pediatric Considerations, Personalized Approaches and Special Situations (Video MP4 Format)

Breakout Epidemiologic Trends – Why the Increase in Incidence Demographic Differences, Atopic Predisposition and Disease Associations (Video MP4 Format)

Breakout Natural History of EoE Does Every Patient Need Treatment (Video MP4 Format)

Breakout Remodeling & Fibrosis. How to Measure, Reversibility and Novel Therapeutics (Video MP4 Format)

BUILDING A BETTER PATH EOSINOPHILS IN EOE (Video MP4 Format)

CLOSING STATEMENTS (Video MP4 Format)

CROSSROADS EOSINOPHILS IN NON EGID GI DISORDERS (Video MP4 Format)

EOE – PATHOGENESIS (Video MP4 Format)

EOE – THERAPEUTIC ADVANCES (Video MP4 Format)

FUNCTIONAL GASTROINTESTINAL DISORDERS (Video MP4 Format)

INFLAMMATORY BOWEL DISEASE (Video MP4 Format)

INTRODUCTION AND PROGRAM OVERVIEW (Video MP4 Format)

NEW PATHS EOSINOPHILS IN EGIDS (Video MP4 Format)

SUMMARY OF BREAKOUT GROUPS (Video MP4 Format)

SUMMARY OF BREAKOUT GROUPS[2] (Video MP4 Format)

 

 

* Detail:

EoE BUILDING A BETTER PATH: EOSINOPHILS IN EOE

Introduction Alex Straumann, MD – University of Zurich

Historical Perspective on EoE: Charting an Undiscovered Disease Stephen Attwood, MD – Durham University, United Kingdom

Global impact and Historical Perspective Alex Straumann, MD – University of Zurich

Patient Presentations – Consider Patient 0 Patient Jeffery O. and Mary M.

EoE – Pathogenesis Moderator Introduction  Sandeep Gupta, MD – Indiana University

Epidemiology: When and Where Did the Path Begin? Evan Dellon, MPH, MD – University of North Carolina School of Medicine

Genetics and Epigenetics: Genetic Determinants of the Path Marc Rothenberg, MD, PhD – Children’s Hospital Medical Center

Fibrosis: Influence of Subepithelial Activity on the Path Seema Aceves, PhD, MD – University of California, San Diego School of Medicine

Allergic Mechanisms: Crossroads with Food, Environmental and Extraesophageal Atopy (OIT, Food, Environmental) Jonathan Spergel, MD, PhD – Children’s Hospital of Philadelphia

Mast Cells and Epithelial Barrier Dysfunction: Inroads and Crossroads Joshua Wechsler, MD – Ann & Robert H. Lurie Children’s Hospital of Chicago

Summary and Discussion Quan Nhu, MD, Dominique Bailey, MD and Joy Chang, MD

EoE – Therapeutic Advances Moderator Introduction David Katzka, MD – Mayo Clinic

Diet Therapy Alfredo Lucendo, MD, PhD – Hospital General de Tomelloso

PPIs: Mechanism and Pathways in the Post AGREE Era Javier Molina-Infante, MD, PhD – Universitario San Pedro de Alcantara

Swallowed Topical Steroids: Repaving a Well-Trodden Path (Efficacy of Newest Agents, Maintenance, Safety) Gary Falk, MD – University of Pennsylvania Perelman School of Medicine

Biologics and Immune Modulators: Charting a New Course Ikuo Hirano, MD – Northwestern University School of Medicine

Therapeutics: Discussion Speaker Panel

BREAKOUTS

Diet Therapy. SOFEED, Novel Monitoring Ready for Prime TimeJohn Leung MD, Nirmala Gonsalves, MD, Kara Kliewer, RD and Bethany Doerfler, RD

Endpoints of Medical Therapy in Adults: Resolution of Inflammation David Katzka, MD, Margaret Collins, MD, Ikuo Hirano, MD, Jonathan Spergel, MD, PhD and Thomas Greuter, MD

SUMMARY OF BREAKOUT GROUPS

Case Presentation-EGE: Adult Gary Falk, MD – University of Pennsylvania Perelman School of Medicine Patient Lisa L.

Epidemiology: When and Where Did This Path Begin Elizabeth Jensen, PhD – Wake Forest School of Medicine

Clinical Features and Natural History: A Long and Winding Road Chris Liacouras, MD – Children’s Hospital of Philadelphia

Pathology: Diagnostic Thresholds for Eosinophil Density: New Roadmaps for an Old Disease Robert Genta, MD – Baylor College of Medicine

Pathology: Histologic Features Beyond Eosinophils: Off the Beaten Path Margaret Collins, MD – Cincinnati Children’s Hospital Medical Center

Pathogenesis: Building Bridges to Better Understanding Glenn Furuta, MD – Children’s Hospital Colorado

Outcomes and Biomarkers: Inroads into Uncharted Territory? Paneez Khoury, MD, MHSc – National Institute of Health

Therapeutics: Diet Therapies Nirmala Gonsalves, MD – Northwestern Memorial Hospital

Therapeutics: Novel Directions Kathryn Peterson, MD – University of Utah

Discussion Speaker Panel

Non-EGID Disorders: CROSSROADS: EOSINOPHILS IN NON EGID GI DISORDERS

CON: Achalasia in Not an EGID John Pandolfino, MD – Northwestern University

Consensus and Discussion Panel

INFLAMMATORY BOWEL DISEASE

Introduction Glenn Furuta, MD – Children’s Hospital Colorado Role of Eosinophils in IBD

Theresa Pizarro, PhD – Case Western Reserve University School of Medicine

Remodeling in IBD. Lessons for EGIDs Florian Rieder, MD – Cleveland Clinic Foundation

Management of IBD: Lessons for EGIDS Steven Hanauer, MD – Northwestern University Feinberg School of Medicine

Summary, Discussion and Q&A Panel

FUNCTIONAL GASTROINTESTINAL DISORDERS

Moderator Introduction John Pandolfino, MD – Northwestern University

PRO: Functional GI disorders are EGIDs Nicholas Talley, MD, PhD – University of Sydney, Australia

CON: Functional GI Disorders are Not EGIDs Brian Lacy, MD, PhD – Mayo Clinic